| Company Name: | Cameco Corporation | | Ticker Symbol: | CCJ | | | WWW Address: | www.cameco.com | | CEO: | Gerald W. Grandey | | No. of Employees: | 1,636 | | Common Issue Type: | CS | | Business Description: | The Company is a uranium producer, supplier of conversion services and Candu fuel manufacturer in Canada.
|
| | | Industry Information: | METALS & MINING - Industrial Metals & Minerals [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 29.65 |  -0.6 | 29.35 | 29.6 | 29.8 | 30.09 | 29.37 | 1627263 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 11,640.6 | 392.6 | 1.75 | 1.05 | 0.23 | 26.0 | 0.8 | 32.17 - 12.85 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 29.65 | $ | | PE Ratio - LTM | 26.0 | |
| Market Capitalisation | 11,639.6 | mil |
| Latest Shares Outstanding | 392.6 | mil |
| Earnings pS (EPS) | 1.05 | $ |
| Dividend pS (DPS) | 0.23 | ¢ |
| Dividend Yield | 0.8 | % |
| Dividend Payout Ratio | 22 | % |
| Revenue per Employee | 1,439,366 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | 0.0 | % |
| Foreign Sales | 1,629 | mil |
| Domestic Sales | 726 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 3.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 40.9 | % |
| EBITDA Margin | 37.8 | % |
| Pre-Tax Profit Margin | 18.3 | % |
| Assets Turnover | 0.4 | % |
| Return on Assets (ROA) | 7.1 | % |
| Return on Equity (ROE) | 11.8 | % |
| Return on Capital Invested (ROCI) | 9.9 | % |
| Current Ratio | 2.2 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 8.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.21 | |
| LT Debt/Total Capital | 16.0 | % |
| Working Capital pS | 1.91 | $ |
| Cash pS | 0.77 | $ |
| Book-Value pS | 9.29 | $ |
| Tangible Book-Value pS | 8.69 | $ |
| Cash Flow pS | 1.87 | $ |
| Free Cash Flow pS | -0.94 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.19 | |
| Price/Tangible Book Ratio | 3.41 | |
| Price/Cash Flow | 15.9 | |
| Price/Free Cash Flow | -31.6 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 178.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 08/12/2009 |
| Dividend Ex-Date | 09/27/2009 |
| Dividend Record Date | 09/29/2009 |
| Dividend Pay Date | 10/14/2009 |
| Dividend Amount | 60 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.24 |
| Current Dividend Yield | 0.8 |
| 5-Y Average Dividend Yield | 0.6 |
| Payout Ratio | 22.0 |
| 5-Y Average Payout Ratio | 16.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.4 | 101 | 21,143 | 98,251 |
| 4 Weeks | 31.52 | 26.66 | 30.42 | -2.5 | 96 | 23,678 | 473,558 |
| 13 Weeks | 32.17 | 25.39 | 28.97 | 2.3 | 96 | 20,850 | 1,334,406 |
| 26 Weeks | 32.17 | 22.61 | 26.06 | 13.8 | 92 | 20,354 | 2,584,911 |
| 52 Weeks | 32.17 | 12.85 | 12.98 | 128.4 | 167 | 25,780 | 6,470,787 |
| YTD | 32.17 | 12.85 | - | 71.9 | 142 | 25,715 | 5,785,768 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 29.95 | 29.77 | 29.09 | 27.27 | 24.38 | 1.75 | 1.64 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 28.39 | 94.8 | 16.76 |
| Income | 19.82 | 79.5 | 4.88 |
| Dividend | 25.89 | 95.0 | 22.60 |
| Capital Spending | 52.82 | NA | 50.31 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 26.98 | NA | 1.39 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 0.4 | 9.5 | 1.3 |
| Earnings % | -0.2 | 44.0 | -11.5 |
| EPS % | -5.7 | 31.5 | -7.3 |
| EPS $ | -0.04 | 0.13 | -0.08 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 11.00 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.30 |
| Receivables Turnover | 4.6 |
| Average Collection Period | 78 |
| Working Capital/Equity | 21.9 |
| Working Capital pS | 1.84 |
| Cash-Flow pS | 1.78 |
| Free Cash-Flow pS | -1.21 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.32 |
| Financial Leverage Ratio (Assets/Equity) | 2.0 |
| Debt Ratio | 49.9 |
| Total Debt/Equity (Gearing Ratio) | 0.37 |
| LT Debt/Equity | 0.35 |
| LT Debt/Capital Invested | 55.1 |
| LT Debt/Total Liabilities | 34.7 |
| Interest Cover | 9.0 |
| Interest/Capital Invested | 0.87 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 19.86 |
| Tobin's Q Ratio | 2.02 |
| Current P/E Ratio - LTM | 26.00 |
| Enterprise Value (EV)/EBITDA | 15.20 |
| Enterprise Value (EV)/Free Cash Flow | -33.14 |
| Dividend Yield | 0.8 |
| Price/Tangible Book Ratio - LTM | 3.41 |
| Price/Book Ratio - LTM | 3.19 |
| Price/Cash Flow Ratio | 15.9 |
| Price/Free Cash Flow Ratio - LTM | -31.6 |
| Price/Sales Ratio | 4.48 |
| P/E Ratio (1 month ago) - LTM | 27.1 |
| P/E Ratio (26 weeks ago) - LTM | 24.8 |
| P/E Ratio (52 weeks ago) - LTM | 10.8 |
| 5-Y High P/E Ratio | 59.6 |
| 5-Y Low P/E Ratio | 11.0 |
| 5-Y Average P/E Ratio | 36.6 |
| Current P/E Ratio as % of 5-Y Average P/E | 71 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 178.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 25.6 |
| PER SHARE FIGURES |
| LT Debt pS | 2.90 |
| Current Liabilities pS | 2.13 |
| Tangible Book Value pS - LTM | 8.69 |
| Book Value pS - LTM | 9.29 |
| Capital Invested pS | 9.92 |
| Cash pS - LTM | 0.77 |
| Cash Flow pS - LTM | 1.87 |
| Free Cash Flow pS - LTM | -0.94 |
| Earnings pS (EPS) | 1.05 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -17.65 |
| Free Cash Flow Margin 5YEAR AVG | -2.67 |
| Net Profit Margin | 15.7 |
| Net Profit Margin - 5YEAR AVRG. | 18.6 |
| Equity Productivity | 0.81 |
| Return on Equity (ROE) | 12.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 12.9 |
| Capital Invested Productivity | 0.60 |
| Return on Capital Invested (ROCI) | 9.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 10.1 |
| Assets Productivity | 0.40 |
| Return on Assets (ROA) | 6.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | 6.6 |
| Gross Profit Margin | 40.9 |
| Gross Profit Margin - 5YEAR AVRG. | 40.4 |
| EBITDA Margin - LTM | 37.8 |
| EBIT Margin - LTM | 20.6 |
| Pre-Tax Profit Margin | 17.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 20.8 |
| Effective Tax Rate | -5.1 |
| Effective Tax Rate - 5YEAR AVRG. | 2.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 191 |
| Revenue per Employee | 1,439,366 |
| Net Income per Employee | 226,599 |
| Average Collection Period | 78 |
| Receivables Turnover | 4.6 |
| Day's Inventory Turnover Ratio | 113 |
| Inventory Turnover | 3.2 |
| Inventory/Sales | 16.5 |
| Accounts Payble/Sales | 20.32 |
| Assets/Revenue | 2.50 |
| Net Working Capital Turnover | 3.71 |
| Fixed Assets Turnover | 0.53 |
| Total Assets Turnover | 0.4 |
| Revenue per $ Cash | 10.62 |
| Revenue per $ Plant | 0.65 |
| Revenue per $ Common Equity | 0.81 |
| Revenue per $ Capital Invested | 0.60 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 4.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 6.4 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
| | |  |  | |
| |